Cleveland-Cliffs Inc.

▲ Bull Case

• ◆Section 232 enhancement + reshoring create a sustained domestic steel price floor: Tariff scope expansion to processed/fabricated steel (under active discussion at USTR) plus CHIPS Act / IRA-driven manufacturing onshoring add 5–10M tons of incremental structural steel demand through 2030, pushing HRC sustained above $900/ton, mid-cycle EBITDA to $2.5–3.0B, and equity value to $25–32/share.
• ◆Slab contract step-up + Stelco synergies validate the strategic narrative: The $500M EBITDA tailwind from the slab-contract roll-off (effective 2026) combined with Stelco's $120M+ run-rate synergies adds ~$600M to EBITDA, accelerating Net Debt/EBITDA to 2.5x by 2028 and unlocking buyback resumption — historically a 15–25% stock catalyst.
• ◆GM Supplier of the Year + Palantir AI deal demonstrate franchise depth and cost-reduction optionality: The GM award is hard evidence that mini-mill encroachment fears have been overpriced; combined with Palantir's enterprise AI platform — which at 3–5% controllable cost reduction yields $150–250M EBITDA — creates a quality re-rating thesis that pushes CLF from STLD-discount toward NUE-parity multiples.

▼ Bear Case

• ◆Balance sheet is materially worse than prior research portrayed and limits downside cushion: Net debt of $7.7B plus $2.5–3.0B pension/OPEB underfunding creates ~$10.5B economic obligation. At trough EBITDA of $700M, leverage is ~15x — unsustainable. A second-trough scenario (HRC < $650/ton through 2027) would force dilutive equity issuance at $8–10/share, taking share count from 570M to 700M+ and eliminating cycle-recovery upside per share.
• ◆Mini-mill automotive qualification timeline is tightening: Nucor Brandenburg achieved partial Tier-2 automotive qualification (estimated 2026 — faster than the 2027–2028 base case). If Nucor wins direct OEM contracts at Ford or GM by 2027, CLF loses 10–15% of its highest-margin volume, pulling mid-cycle EBITDA from $1.85B to $1.4B and equity value to $5–8/share.
• ◆Section 232 modifications under trade-deal pressure remain a binary tail risk: Bipartisan support exists today, but trade negotiations with EU/Japan/Korea historically produce TRQ concessions. A 5M-ton TRQ allowance permanently compresses domestic HRC pricing by $75–125/ton, removing $1.0–1.5B from CLF's annual EBITDA — and with current leverage, that EBITDA loss directly threatens covenant compliance.

“The central question Wall Street is debating: Is the recent rally the start of a multi-quarter re-rating, or a positioning bounce that fades into the next HRC weakness? Bulls argue the slab-contract removal is a permanent step-up (not a cycle bet); GM/Palantir validate operational improvement; Section 232 is durable; current multiple (9.1x trailing EV/EBITDA but ~6.0x mid-cycle EBITDA) is below peer-average mid-cycle multiples. Bears argue Q1 2026 actual EBITDA was $95M (annualized $380M, far below mid-cycle); leverage is too high to survive a second-leg-down; pension/OPEB obligation is ignored in EV/EBITDA optics; consensus 2026 revenue $10.2B vs. Q1 annualized $19.6B shows analysts are modeling undisclosed portfolio actions. Consensus 12-month price target: $11.97 (below current $13.29), with wide dispersion (low $6–8, high $20–22), reflecting the binary nature of cyclical bets.”

• ◆HRC spot price sustained above $850/ton — single largest near-term catalyst; +$1.6B EBITDA per $100/ton move
• ◆Section 232 scope expansion to processed goods or TRQ removal — bipartisan but pending; +$300–500M annual EBITDA per meaningful expansion
• ◆Slab contract termination flow-through — $500M EBITDA tailwind now in run-rate (effective 2026)
• ◆GM Supplier of the Year translates to incremental volume — May 2026 award; quantification to come in Q2 2026 disclosures
• ◆Palantir AI partnership cost savings realization — 3-year deal; $150–250M EBITDA at 3–5% controllable opex reduction
• ◆Stelco synergy run-rate disclosure reaches $120M+ — quarterly tracking toward full realization
• ◆Net Debt/EBITDA falls below 2.5x — management leverage target; would unlock buyback resumption
• ◆Auto SAAR recovery to 16M+ units sustained — directly correlated with automotive contract demand

• ◆HRC price decline to $550–650/ton (historical trough levels) — would collapse EBITDA to $400–700M and trigger covenant pressure
• ◆Section 232 reduction under trade deal pressure — binary policy risk; -$1.0–2.0B EBITDA in full-removal scenario
• ◆Refinancing risk on 2027–2028 debt maturities — current leverage at risk of escalating to 5x+; dilutive equity at $8–10
• ◆Nucor Brandenburg automotive qualification acceleration to 2027 — would capture 10–15% of CLF's highest-margin auto volume
• ◆Chinese steel overcapacity export pressure weakens global price floor — indirect US pressure via tariff arbitrage
• ◆Auto SAAR weakness sustained below 15M units — cuts CLF demand by $400–800M annually
• ◆USW strike risk in 2027–2028 contract cycle — $50–100M/week production loss during labor action
• ◆Pension/OPEB underfunding worsens with falling interest rates — re-widens funded-status gap by $500M–1B